Biocartis Group (Belgium) Today
| BCART Stock | EUR 0.29 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 70
|
Biocartis Group is trading at 0.29 as of the 17th of December 2024, a No Change since the beginning of the trading day. The stock's open price was 0.29. Biocartis Group has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of April 2024 and ending today, the 17th of December 2024. Click here to learn more.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. The company has 93.1 M outstanding shares. More on Biocartis Group NV
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biocartis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biocartis Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biocartis Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
Biocartis Group NV (BCART) is traded on Euronext Brussels in Belgium and employs 619 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biocartis Group's market, we take the total number of its shares issued and multiply it by Biocartis Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biocartis Group NV operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 93.1 M outstanding shares.
Biocartis Group NV has accumulated about 53.52 M in cash with (65.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Biocartis Group Probability Of Bankruptcy
Ownership AllocationBiocartis Group holds a total of 93.1 Million outstanding shares. Biocartis Group NV shows 6.66 percent of its outstanding shares held by insiders and 27.71 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biocartis Ownership Details
Biocartis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biocartis Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Biocartis Group Corporate Management
Elected by the shareholders, the Biocartis Group's board of directors comprises two types of representatives: Biocartis Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biocartis. The board's role is to monitor Biocartis Group's management team and ensure that shareholders' interests are well served. Biocartis Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biocartis Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reginald Genechten | Head Chain | Profile | |
| Benoit Devogelaere | Chief Officer | Profile | |
| Erwin Sablon | Head Management | Profile | |
| Geert Maertens | Chairman Officer | Profile | |
| JeanMarc Roelandt | Chief Officer | Profile | |
| Piet Houwen | Chief Officer | Profile | |
| Renate Degrave | Head Communications | Profile |
Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.